Adverse Reactions Chemotherapy Events FDA 
pharmaphorum
APRIL 1, 2021
The FDA has approved Sanofi’s Sarclisa (isatuximab) in combination with a new chemotherapy regimen for advanced multiple myeloma, building on a first approval last year. In the trial, 8% of patients dropped out because of adverse events and 2.8% quit because of an infection.
pharmaphorum
JANUARY 26, 2022
The FDA has placed a partial clinical fold on clinical trials of Gilead Sciences’ magrolimab, the centre piece of its $4.9 The post FDA slaps hold on trials of Gilead’s CD47 drug magrolimab appeared first on. billion acquisition of Forty Seven in 2020.
The Checkup by Singlecare
OCTOBER 16, 2023
Food and Drug Administration (FDA) in 2004 , Cymbalta has become a widely used antidepressant to treat various mental health and pain-related conditions. Cymbalta may have several off-label uses in addition to its FDA-approved uses. It is also approved for fibromyalgia and chronic muscle pain. Approved by the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content